HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome.

AbstractOBJECTIVE:
To investigate the role of corticosteroids in the initial treatment of Kawasaki disease (KD).
STUDY DESIGN:
Between September 2000 and March 2005, we randomly assigned 178 KD patients from 12 hospitals to either an intravenous immunoglobulin (IVIG) group (n = 88; 1 g/kg for 2 consecutive days) or an IVIG plus corticosteroid (IVIG+PSL) group (n = 90). The primary endpoint was coronary artery abnormality (CAA) before a 1-month echocardiographic assessment. Secondary endpoints included duration of fever, time to normalization of serum C-reactive protein (CRP), and initial treatment failure requiring additional therapy. Analyses were based on intention to treat.
RESULTS:
Baseline characteristics of groups were similar. Fewer IVIG+PSL patients than IVIG patients had a CAA before 1 month (2.2% vs 11.4%; P = .017). The duration of fever was shorter (P < .001) and CRP decreased more rapidly in the IVIG+PSL group than in the IVIG group (P = .001). Moreover, initial treatment failure was less frequent (5.6% vs 18.2%; P = .010) in the IVIG+PSL group. All patients assigned to the IVIG+PSL group completed treatment without major side effects.
CONCLUSIONS:
A combination of corticosteroids and IVIG improved clinical course and coronary artery outcome without causing untoward effects in children with acute KD.
AuthorsYoshinari Inoue, Yasunori Okada, Makoto Shinohara, Tohru Kobayashi, Tomio Kobayashi, Takeshi Tomomasa, Kazuo Takeuchi, Akihiro Morikawa
JournalThe Journal of pediatrics (J Pediatr) Vol. 149 Issue 3 Pg. 336-341 (Sep 2006) ISSN: 0022-3476 [Print] United States
PMID16939743 (Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial)
Chemical References
  • Glucocorticoids
  • Immunoglobulins, Intravenous
  • Immunologic Factors
  • Prednisolone
Topics
  • Child
  • Child, Preschool
  • Coronary Aneurysm (chemically induced, diagnostic imaging, prevention & control)
  • Drug Therapy, Combination
  • Female
  • Glucocorticoids (administration & dosage, adverse effects)
  • Humans
  • Immunoglobulins, Intravenous (administration & dosage)
  • Immunologic Factors (administration & dosage)
  • Infant
  • Male
  • Mucocutaneous Lymph Node Syndrome (diagnostic imaging, drug therapy)
  • Prednisolone (administration & dosage, adverse effects)
  • Prospective Studies
  • Treatment Outcome
  • Ultrasonography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: